Advertisement

Topics

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity,Overweight, Date of authorisation: 23/03/2015, Revision: 6, Status: Authorised

11:00 EDT 16 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity,Overweight, Date of authorisation: 23/03/2015, Revision: 6, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity,Overweight, Date of authorisation: 23/03/2015, Revision: 6, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity,Overweight, Date of authorisation: 23/03/2015, Revision: 6, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...